Surgical hemostasis adjunct

A surgical hemostasis adjunct is indicated for intraoperative bleeding across diverse tissue beds when primary or standard surgical techniques—such as direct pressure, suture ligation, or electrocautery—are ineffective or impractical Pathophysiologically, the condition represents persistent local hemorrhage that risks tissue damage, hemodynamic instability, or hematoma formation, necessitating secondary topical support to accelerate clot propagation, mechanically scaffold platelet aggregation, o...

A surgical hemostasis adjunct is indicated for intraoperative bleeding across diverse tissue beds when primary or standard surgical techniques—such as direct pressure, suture ligation, or electrocautery—are ineffective or impractical This clinical state involves local vascular disruption, low-pressure venous oozing, capillary bed seepage, or bleeding from friable, irregular, and anatomically inaccessible parenchyma, which can occur in pediatric or adult surgical populations

A surgical hemostasis adjunct is indicated for intraoperative bleeding across diverse tissue beds when primary or standard surgical techniques—such as direct pressure, suture ligation, or electrocautery—are ineffective or impractical Pathophysiologically, the condition represents persistent local hemorrhage that risks tissue damage, hemodynamic instability, or hematoma formation, necessitating secondary topical support to accelerate clot propagation, mechanically scaffold platelet aggregation, o...

This clinical state involves local vascular disruption, low-pressure venous oozing, capillary bed seepage, or bleeding from friable, irregular, and anatomically inaccessible parenchyma, which can occur in pediatric or adult surgical populations

Pathophysiologically, the condition represents persistent local hemorrhage that risks tissue damage, hemodynamic instability, or hematoma formation, necessitating secondary topical support to accelerate clot propagation, mechanically scaffold platelet aggregation, or supplement coagulation factors directly at the site of vascular injury

Pathophysiologically, the condition represents persistent local hemorrhage that risks tissue damage, hemodynamic instability, or hematoma formation, necessitating secondary topical support to accelerate clot propagation, mechanically scaffold platelet aggregation, or supplement coagulation factors directly at the site of vascular injury